Role of probiotics in treatment of nonalcoholic fatty liver disease / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 77-80, 2017.
Article
em Zh
| WPRIM
| ID: wpr-808047
Biblioteca responsável:
WPRO
ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in China and manifests as simple fatty liver, non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. Studies have shown that intestinal flora can affect the development and progression of NAFLD via the "gut-liver axis" . Probiotics are active microorganisms with beneficial effects on the host, and more and more studies have found that probiotics play a positive role in improving NAFLD. They are cheaper, less harmful, and safer compared with antibiotics and surgery, and therefore, it may become a new method for the prevention and treatment of NAFLD. This article reviews the research advances in probiotics in the treatment of NAFLD, in order to provide a basis for the treatment of NAFLD using probiotics.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Hepatology
Ano de publicação:
2017
Tipo de documento:
Article